BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 38568932)

  • 1. Irritable Bowel Syndrome Is Associated With Brain Health by Neuroimaging, Behavioral, Biochemical, and Genetic Analyses.
    Li Z; Ma Q; Deng Y; Rolls ET; Shen C; Li Y; Zhang W; Xiang S; Langley C; Sahakian BJ; Robbins TW; Yu JT; Feng J; Cheng W
    Biol Psychiatry; 2024 Jun; 95(12):1122-1132. PubMed ID: 38199582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical activity, sedentary behavior, and the risk of functional gastrointestinal disorders: A two-sample Mendelian randomization study.
    Wu YR; Tan ZB; Lu Y; Liu C; Dong WG
    J Dig Dis; 2024 May; ():. PubMed ID: 38808604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of depression-mediated gut microbiota composition on Irritable Bowel Syndrome: A Mendelian study.
    Huang Y; Zheng E; Hu M; Yang X; Lan Q; Yu Y; Xu B
    J Affect Disord; 2024 May; 360():15-25. PubMed ID: 38801922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causality of genetically determined blood metabolites on irritable bowel syndrome: A Mendelian randomization study.
    Dai X; Liang M; Dai Y; Ding S; Sun X; Xu L
    PLoS One; 2024; 19(4):e0298963. PubMed ID: 38568932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the causal effects of blood metabolites on irritable bowel syndrome: Mendelian randomization.
    Zeng Y; Liu H; Pei Z; Li R; Liu Z; Liao C
    BMC Gastroenterol; 2024 Jan; 24(1):19. PubMed ID: 38182988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring causality in the association between gut microbiota and irritable bowel syndrome risk: a large Mendelian randomization study.
    Zhang J; Shi X; Wang Y
    Aging (Albany NY); 2024 Apr; 16(8):7448-7459. PubMed ID: 38669090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Causality of genetically determined metabolites on anxiety disorders: a two-sample Mendelian randomization study.
    Xiao G; He Q; Liu L; Zhang T; Zhou M; Li X; Chen Y; Chen Y; Qin C
    J Transl Med; 2022 Oct; 20(1):475. PubMed ID: 36266699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irritable bowel syndrome and migraine: evidence from Mendelian randomization analysis in the UK Biobank.
    Chen J; Chen X; Xie Y; Sun Y; Wang X; Hesketh T
    Expert Rev Gastroenterol Hepatol; 2021 Oct; 15(10):1233-1239. PubMed ID: 34176420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major depressive disorder and irritable bowel syndrome risk: A Mendelian randomization study.
    Sun G; Jiang Y
    PLoS One; 2024; 19(3):e0300251. PubMed ID: 38483921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medium-chain and long-chain fatty acids are associated with diarrheal predominant irritable bowel syndrome revealed by DESI-MSI.
    Zhang Y; Zhu H; Du S; Wang H; Li H; Wang M; Shao B
    J Gastroenterol; 2023 Nov; 58(11):1124-1133. PubMed ID: 37578536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide multi-trait analysis of irritable bowel syndrome and related mental conditions identifies 38 new independent variants.
    Alemany S; Soler-Artigas M; Cabana-Domínguez J; Fakhreddine D; Llonga N; Vilar-Ribó L; Rodríguez-Urrutia A; Palacio J; González-Castro AM; Lobo B; Alonso-Cotoner C; Simrén M; Santos J; Ramos-Quiroga JA; Ribasés M
    J Transl Med; 2023 Apr; 21(1):272. PubMed ID: 37085903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the causal relationships between human blood metabolites and the risk of NAFLD: A comprehensive mendelian randomization study.
    Guo Z; Zhang T; Yun Z; Jin Q; Cao X; Kong D; Yao Y; Li X; Zhang J; Ye Y
    Front Genet; 2023; 14():1108086. PubMed ID: 37056283
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessing the causal association between human blood metabolites and the risk of epilepsy.
    Cai J; Li X; Wu S; Tian Y; Zhang Y; Wei Z; Jin Z; Li X; Chen X; Chen WX
    J Transl Med; 2022 Sep; 20(1):437. PubMed ID: 36180952
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.